●株式シェア99.96%を1億3,500万ドルで取得
●買収により医薬品、バイオシミラー、有効成分の生産を増強
トルコ製薬大手のエジザージュバシュ(Eczacibasi)は6月29日、米アムジェンの...
中・東欧、CIS諸国、ロシアに特化した情報誌
その他産業
この記事の要約
●株式シェア99.96%を1億3,500万ドルで取得●買収により医薬品、バイオシミラー、有効成分の生産を増強トルコ製薬大手のエジザージュバシュ(Eczacibasi)は6月29日、米アムジェンの…この記事は東欧経済ニ […]
●株式シェア99.96%を1億3,500万ドルで取得
●買収により医薬品、バイオシミラー、有効成分の生産を増強
トルコ製薬大手のエジザージュバシュ(Eczacibasi)は6月29日、米アムジェンの...
Cookie | 期間 | 説明 |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |